Synthesis and mass spectrometric fragmentation characteristics of imidazole ribosides-analogs of intermediates of purine de novo synthetic pathway
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
17065098
DOI
10.1080/15257770600894691
PII: W726806316325200
Knihovny.cz E-resources
- MeSH
- Aminoimidazole Carboxamide analogs & derivatives chemistry MeSH
- Biochemistry methods MeSH
- Models, Chemical MeSH
- Mass Spectrometry methods MeSH
- Ions MeSH
- Molecular Structure MeSH
- Purines chemistry MeSH
- Ribonucleosides chemical synthesis chemistry MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- acadesine MeSH Browser
- Aminoimidazole Carboxamide MeSH
- Ions MeSH
- Purines MeSH
- Ribonucleosides MeSH
Two inherited deficiencies have been described in purine de novo synthesis pathway. Both the defects are diagnosed by detecting ribosides--dephosphorylated substrates of the enzymes--in patient's urine. We describe here a synthesis and mass spectrometric fragmentation of ribosides potentially of diagnostic importance for defects in the second part of the pathway. All the species, except 5-amino-4-imidazolesuccinocarboxamideriboside can be synthesized from the commercially available 5-amino-4-imidazolecarboxamideriboside by chemical methods. Fragmentation spectra of the compounds were obtained by the ion trap mass spectrometry. During fragmentation an opening of the imidazole ring was not observed for any of the compounds but loss of its substituents in the form of small molecules (NH3, CO2, CO) is the major route of fragmentation. The ribose moiety cleaves off molecule(s) of water, undergoes a cross-ring cleavage or breaks away as a whole.
References provided by Crossref.org